The Guidelines for Febril Neutropenic Patients: The Comparison of Guidelines of IDSA and ECIL
Infections are one of the major cause of death in the patients with hemato-oncological cancer. The prevention and appropriate treatment of infections is lifesaving. Infectious Diseases Society of America (IDSA)-licensed guideline “Clinical practice guideline for the use of antimicrobial agents in ne...
Main Author: | Bircan KAYAASLAN |
---|---|
Format: | Article |
Language: | English |
Published: |
Bilimsel Tip Yayinevi
2016-03-01
|
Series: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
Subjects: | |
Online Access: | http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2016-21-01-001-009.pdf |
Similar Items
-
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01) -
The Organisms Isolated During Febrile Neutropenic Episodes
by: Kürşat KAPTAN, et al.
Published: (1999-03-01) -
Evaluation of Febrile Neutropenic Attacks
by: Nebahat DİKİCİ, et al.
Published: (2002-09-01) -
The Evaluation of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
by: Kemalettin AYDIN, et al.
Published: (2007-06-01) -
Investigation of Febrile Neutropenic Cases and Risk Factors
by: Mehmet ÖZDEN, et al.
Published: (2013-12-01)